Cervical cancer epidemiology and demographics

Jump to navigation Jump to search

Cervical cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cervical Cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cervical Cancer During Pregnancy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cervical cancer epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cervical cancer epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cervical cancer epidemiology and demographics

CDC on Cervical cancer epidemiology and demographics

Cervical cancer epidemiology and demographics in the news

Blogs on Cervical cancer epidemiology and demographics

Directions to Hospitals Treating Cervical cancer

Risk calculators and risk factors for Cervical cancer epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]

Overview

Worldwide, cervical cancer is the third most common cancer among women and the second most frequent cause of cancer-related death, accounting for nearly 300,000 deaths annually.[1] In developing nations, it is often the most common cause of cancer-related death among women and a leading cause of death overall.[1] Once one of the most common cancers affecting U.S. women, cervical cancer now ranks 14th in frequency.[1] Because precancerous lesions found by Pap smears can be treated and cured before they develop into cancer, and because cervical cancer is often detected before it becomes advanced, the incidence and death rates for this disease are relatively low.[1] According to the most recent data, the age-adjusted incidence rate for cervical cancer was 6.73 cases per 100,000 women in the United States in 2011.[2]

Epidemiology and Demographics

Prevalence

  • In the United States, the age-adjusted prevalence of cervical cancer is 87.9 per 100,000 in 2011.[2]

Incidence

  • The delay-adjusted incidence of cervical cancer in 2011 was estimated to be 6.83 per 100,000 persons in the United States.[2]
  • In 2011, the age-adjusted incidence of cervical cancer was 6.73 per 100,000 persons in the United States.[2]
  • In Great Britain, the incidence is 8.8/100,000 per year (2001), similar to the rest of Northern Europe, and mortality is 2.8/100,000 per year (2003) (Cancer Research UK Cervical cancer statistics for the UK). With a 42% reduction from 1988-1997 the National Health Service (NHS) implemented screening programme has been highly successful, screening the highest risk age group (25-49 years) every 3 years, and those ages 50-64 every 5 years. In 2011, 3,064 women in the United Kingdom were diagnosed with cervical cancer.[3]

Age

  • While the overall age-adjusted incidence of cervical cancer in the United States between 2007 and 2011 is 7.8 per 100,000, the age-adjusted incidence of cervical cancer by age category is:[2]
    • Under 65 years: 7.3 per 100,000
    • 65 and over: 11.5 per 100,000

Race

  • Shown below is a table depicting the age-adjusted prevalence of cervical cancer by race in 2011 in the United States.[2]
All Races White Black Asian/Pacific Islander Hispanic
Age-adjusted prevalence 87.9 per 100,000 91.3 per 100,000 81.9 per 100,000 75.5 per 100,000 141 per 100,000
  • Shown below is an image depicting the incidence of cervical cancer in the white and black races in the United States between 1975 and 2011.[2]

The incidence of cervical cancer in the white and black races in the United States between 1975 and 2011

  • Shown below is an image depicting the incidence of cervical cancer by race in the United States between 1975 and 2011.[2]

The incidence of cervical cancer by race in the United States between 1975 and 2011

API: Asian/Pacific Islander; AI/AN: American Indian/ Alaska Native

Developed Countries

  • As recently as the 1940s, cervical cancer was a major cause of death among women of childbearing age in the United States. However, with the introduction in the 1950s of the Papanicolaou (Pap) smear―a simple test in which a sample of cervical cells is examined under a microscope to detect cellular abnormalities―the incidence of invasive cervical cancer declined dramatically. Between 1955 and 1992, U.S. cervical cancer incidence and death rates declined by more than 60%.[1]
  • Once one of the most common cancers affecting U.S. women, cervical cancer now ranks 14th in frequency. Because precancerous lesions found by Pap smears can be treated and cured before they develop into cancer, and because cervical cancer is often detected before it becomes advanced, the incidence and death rates for this disease are relatively low.[1]


  • In certain populations and geographic areas of the United States, cervical cancer incidence and death rates are still high, due in large part to limited access to cervical cancer screening. Rates are also high in developing nations, where more than 80% of cervical cancer cases occur. [1]

Developing Countries

In developing nations, cervical cancer is often the most common cause of cancer-related death among women and a leading cause of death overall.[1]

Percent Distribution of Cervical Cancer by Histology

Among patients with histologically confirmed cases of cervical cancer, the percent distribution of the types of the disease between 2007 and 2011 in the United States are:[2]

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 Cancer advances in focus. Cervical cancer. national cancer institute
  2. 2.0 2.1 2.2 2.3 2.4 2.5 2.6 2.7 2.8 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.
  3. Cancer Research UK

Template:WH Template:WS